Houston Chronicle Features Dr. James Martin’s Congenital Heart Disease Research
Congenital heart disease (CHD) – a spectrum of heart defects that develop before birth – can lead to pediatric heart...
James F. Martin
Collaborating to Develop A New Roadmap for Personalized Medicine
THI’s Cardiomyocyte Renewal Laboratory takes a closer look at the gene expression landscape of congenital heart disease Researchers in the...
New Understanding of Congenital Heart Disease Progression Opens Door to Improved Treatment Options
Scientists Develop a Roadmap to Future Personalized Medicine for Heart Defects that Develop Before Birth HOUSTON, TX – (June...
Dr. Darren Woodside – Texas Heart Institute Vice President for Research – Receives Heralded Fellow Designation by the National Academy of Inventors
HOUSTON, TX (DECEMBER 7, 2021) – The Texas Heart Institute is pleased to announce that Dr. Darren G. Woodside, Senior...
Dr. James Martin – Director of the Cardiomyocyte Renewal Lab at Texas Heart Institute – Elected to the 2021 Class of the National Academy of Inventors
Houston, TX (February 11, 2021) – The Texas Heart Institute is pleased to announce that Dr. James Martin, Director of its...
Sharing Science Globally to Advance Medicine
Texas Heart Institute has been at the forefront of cardiovascular discovery and innovation since its formation. It continues to relentlessly...
Harvard Professor Dr. Christine Edry Seidman to receive The Ray C. Fish Award for Scientific Achievement at the Annual Texas Update Conference
Over the past six decades, physicians and scientists at the Texas Heart Institute have worked diligently with colleagues around the...
Research improves understanding of mechanism of atrial fibrillation
HOUSTON – (Oct. 21, 2019) – Atrial fibrillation is the most common heart arrhythmia in humans. This condition increases the...
New insights into the healing capacity of the heart
HOUSTON – (Sept. 25, 2019) – A group of researchers at the Texas Heart Institute, Baylor College of Medicine and the...
